WHO Steps Up Plan For Speeding Drug Approvals In Resource-Poor Countries
Executive Summary
Drug companies will be expected to play a key role in a proposed drug registration procedure under which resource-strapped regulatory bodies could get products to patients faster by relying on the approvals of “internationally respected” agencies.